Perkins Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Perkins Capital Management’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-24,200	Closed	-$335K	–	106
2022 Q3	$335K	Sell	24,200 -1,000	-4%	-$14.8K	0.37%	67
2022 Q2	$362K	Buy	25,200 +750	+3%	+$13K	0.37%	66
2022 Q1	$553K	Buy	24,450 +1,250	+5%	+$24.3K	0.45%	62
2021 Q4	$436K	Buy	23,200 +1,433	+7%	+$38.3K	0.29%	76
2021 Q3	$715K	Sell	21,767 -28,175	-56%	-$1.05M	0.44%	61
2021 Q2	$2.13M	Sell	49,942 -825	-2%	-$32.3K	1.21%	31
2021 Q1	$1.95M	Sell	50,767 -990	-2%	-$42.1K	1.13%	29
2020 Q4	$2.27M	Sell	51,757 -2,693	-5%	-$101K	1.48%	22
2020 Q3	$2.14M	Buy	+54,450	New	+$1.76M	1.97%	13
2020 Q1	$1.99M	Sell	56,433 -2,350	-4%	-$99.1K	2.4%	10
2019 Q4	$2.86M	Sell	58,783 -9,983	-15%	-$455K	2.56%	7
2019 Q3	$3.27M	Sell	68,766 -7,634	-10%	-$359K	2.82%	6
2019 Q2	$3.28M	Sell	76,400 -3,250	-4%	-$126K	2.3%	11
2019 Q1	$3.08M	Sell	79,650 -4,500	-5%	-$153K	2.03%	10
2018 Q4	$2.4M	Buy	84,150 +14,900	+22%	+$473K	1.86%	14
2018 Q3	$2.71M	Buy	69,250 +900	+1%	+$33.3K	1.63%	13
2018 Q2	$2.21M	Buy	68,350 +7,550	+12%	+$208K	1.58%	10
2018 Q1	$1.33M	Sell	60,800 -200	-0.3%	-$4.81K	1.2%	23
2017 Q4	$1.45M	Sell	61,000 -5,550	-8%	-$140K	1.39%	19
2017 Q3	$1.87M	Sell	66,550 -2,000	-3%	-$60.8K	1.96%	12
2017 Q2	$2.21M	Sell	68,550 -67,500	-50%	-$2.06M	2.45%	9
2017 Q1	$3.85M	Buy	136,050 +8,500	+7%	+$226K	3.97%	3
2016 Q4	$3.09M	Buy	127,550 +15,950	+14%	+$391K	3.39%	4
2016 Q3	$2.65M	Hold	111,600	–	–	2.65%	6
2016 Q2	$2.05M	Buy	111,600 +16,900	+18%	+$264K	2.35%	6
2016 Q1	$982K	Sell	94,700 -59,350	-39%	-$601K	1.23%	28
2015 Q4	$2.33M	Buy	154,050 +8,200	+6%	+$122K	2.5%	6
2015 Q3	$2.31M	Buy	145,850 +47,850	+49%	+$1.21M	2.57%	5
2015 Q2	$2.59M	Sell	98,000 -1,500	-2%	-$48.5K	2.28%	5
2015 Q1	$3.88M	Sell	99,500 -3,200	-3%	-$110K	3.26%	3
2014 Q4	$3.09M	Hold	102,700	–	–	2.65%	4
2014 Q3	$2.43M	Sell	102,700 -27,350	-21%	-$778K	2.05%	8
2014 Q2	$4.05M	Sell	130,050 -3,600	-3%	-$104K	2.85%	3
2014 Q1	$4.25M	Buy	133,650 +24,650	+23%	+$814K	2.98%	4
2013 Q4	$3.74M	Sell	109,000 -123,699	-53%	-$3.6M	2.52%	5
2013 Q3	$4.67M	Sell	232,699 -53,501	-19%	-$1.11M	3.35%	4
2013 Q2	$6.07M	Buy	+286,200	New	+$5.56M	4.82%	1

Other funds holding CSII

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Perkins Capital Management's CSII Position: Q4 2022 in Review

Perkins Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2022, closing a stake of 24,200 shares — an estimated $335K sold.

Perkins Capital Management first reported a position in CSII in Q2 2013 and held it in 37 quarters. The position peaked at $6.07M in Q2 2013. 162 funds tracked by Wall St. Rank hold CSII as of Q4 2022.

Perkins Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q4 2022 after selling out during the quarter.
Perkins Capital Management sold 24,200 Cardiovascular Systems, Inc. shares in Q4 2022, an estimated $335K.
Perkins Capital Management first reported a position in Cardiovascular Systems, Inc. in Q2 2013 and held it in 37 quarters.
Perkins Capital Management's Cardiovascular Systems, Inc. position peaked at $6.07M in Q2 2013.
162 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2022.

Based on Perkins Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.